Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Hongbo Du

Biographic Data

ID6313956
NAMEHongbo Du
GIVEN NAMESHongbo
FAMILY NAMEDu
SIGNATUREDU H
AFFILIATIONSBeijing University of Chinese Medicine
ORCID0000-0002-4406-7608
VERIFIEDYes
TOTAL WORKS3
TOTAL CITATIONS16
AUTHOR COUNT3
EDITOR COUNT0
FIRST PUBLICATION YEAR2007
LATEST PUBLICATION YEAR2025
H-INDEX1
  • Regulatory mechanisms of signaling pathways in liver cancer treatment with traditional Chinese medicine

    Open Access•Shihao Zheng, Tianyu Xue et al.•ARTICLE•Journal of Ethnopharmacology•2025

  • Identification of pseudo-immune tolerance for chronic hepatitis B patients: Development and validation of a non-invasive prediction model

    Open Access•Shuo Li, Zhiguo Li et al.•ARTICLE•Frontiers in Public Health•2023

    Background and aims Patients with chronic hepatitis B (CHB) in the immune tolerant (IT) phase were previously thought to have no or slight inflammation or fibrosis in the liver. In fact, some CHB patients with normal ALT levels still experience liver fibrosis. This study aimed to develop and validate a non-invasive model for identifying pseudo-immune tolerance (pseudo-IT) of CHB by predicting significant liver fibrosis. Methods This multi-center …

  • The short-term land value impacts of urban rail transit: Quantitative evidence from Sunderland, UK

    Open Access•Hongbo Du, Corinne Mulley•ARTICLE•Land Use Policy•2007•Cited by: 16•References: 5

  • The short-term land value impacts of urban rail transit: Quantitative evidence from Sunderland, UK

    Open Access•Hongbo Du, Corinne Mulley•ARTICLE•Land Use Policy•2007•Cited by: 16•References: 5

  • The short-term land value impacts of urban rail transit: Quantitative evidence from Sunderland, UK

    Open Access•Hongbo Du, Corinne Mulley•ARTICLE•Land Use Policy•2007•Cited by: 16•References: 5

  • Identification of pseudo-immune tolerance for chronic hepatitis B patients: Development and validation of a non-invasive prediction model

    Open Access•Shuo Li, Zhiguo Li et al.•ARTICLE•Frontiers in Public Health•2023

    Background and aims Patients with chronic hepatitis B (CHB) in the immune tolerant (IT) phase were previously thought to have no or slight inflammation or fibrosis in the liver. In fact, some CHB patients with normal ALT levels still experience liver fibrosis. This study aimed to develop and validate a non-invasive model for identifying pseudo-immune tolerance (pseudo-IT) of CHB by predicting significant liver fibrosis. Methods This multi-center …

  • Regulatory mechanisms of signaling pathways in liver cancer treatment with traditional Chinese medicine

    Open Access•Shihao Zheng, Tianyu Xue et al.•ARTICLE•Journal of Ethnopharmacology•2025

Internal Medicine (2 works) · Medicine (2 works) · Advertising (1 works) · Alternative medicine (1 works) · Archaeology (1 works) · Area under the curve (1 works) · Attractiveness (1 works) · Aviation Industry Analysis and Trends (1 works) · Biochemistry (1 works) · Biology (1 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae